Just Other Articles

There is a reason why an IT organization is successful. The quality of relationships that IT leaders develop with each other, customers, and other business units directly relate to the success that the IT organization achieves as a whole. The IT executive’s ability to build qualit

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

y relationships and a bridge gaps between sales, marketing, and other lines of business can make or break IT’s success. IT value in the new economy is not about how fast an application responds, but the quality of personal relationships the CIO and IT management develop with other

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

usiness units and customers. Pure technology is essentially black and white. It is the human interactions that makes or breaks many projects and initiatives. This article focuses on one method of measuring the quality of relationships that your Information Technology team develo

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

s – Social Network Analysis.

So, how do you measure the quality of relationships developed within your team? Well, the good news is you already have a good idea who your top performers and bottom performers are without using a set of metrics to figure it out. However, introducing

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

an analysis of relationship metrics could provide you with new insight into team members. As an executive, your interactions with a manager might be drastically different than how that same manager reacts with others in the management chain. Someone who is completely open and help

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

ul to you might not be so upfront and honest with peers. You might also discover some managers are not held in high regard by their peers, or find that a manager who flies under the radar is one of your best assets.

The method outlined here to measure the relationships your organi

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

ation has developed with each other and with business units is called Social Network Analysis (SNA). While Social Network Analysis is less well known, it can be a valuable tool in evaluating the organizational ties of groups and individuals within the groups. The goal of a Social

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

etwork Analysis is to find the structure of an organization which includes information on how organizations are run, how problems are solved, alliances, informal subgroups, and how well individuals achieve their goals.

The foundation of SNA is based on viewing social relationships

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

n terms of individuals (nodes) and relationships between individuals (ties). Each node can have many ties of varying types with other nodes in the network. To gather the node and tie information, a set of simple questions is administered to the individuals aimed at identifying the

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

r positive and negative connections. Examples are: Who do you look to for advice? With whom do you discuss personal matters? Who do you report too? Who are your most valuable subordinates? From whom must you obtain buy-in? Who is your most difficult contact? After gathering

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

odes and tie data within an organization, a social diagram is constructed showing a graphical representation of all nodes and associated ties.

Once data is gathered, a social diagram can be constructed and analyzed. Valuable information can be found which can lead to a better unde

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

rstanding of who the key players are in your organization, who is holding the organization back, who holds influence with others, how decisions are made, how information flows, who trusts who, and who is in the decision making loop. Another key benefit of Social Network Analysis is

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

that it can reveal how informal networks that are key to an organization’s success can differ from official reporting charts and how actual decision making processes differ from previous assumptions.

Organizations who have used Social Network Analysis have reported that they discov

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

red hidden assets that were playing key roles in their team, found individuals viewed as key players that were surprisingly isolated, identified anonymous workers that held powerful influences, and discovered workers who were gatekeepers rather than information sharers.

Con

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

lusion
While an IT executive might already have an idea of who works well with others and who doesn’t, many do not try to quantify which leaders demonstrate good relationship development. Once you can quantify the relationship results, you can start taking action base

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

on your findings. These results also give you another view into who your top performers are, who to reward, and who you can count on for critical projects.

Often, efforts are made to evaluate relationship quality and to try and resolve teamwork issues only when a serious conflict

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

arises. This is the worst time to build relationships as the parties are already in conflict. It is important to implement a relationship evaluation during non confrontational times to increase these skills in your management chain. Since relationship quality is key to an organiz

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

tion’s success, these metrics can provide you with another means to evaluate your organization and how to raise the bar with your customers.

Good relationships also foster understanding of other group’s business goals and processes. It is the IT executive’s responsibility to under

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

tand the business and how business processes and teams integrate across the enterprise. An effective technology strategy cannot exist without business process understanding and quality relationships with other the business leaders.

The best organizations have and retain the best p

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

ople. By fostering an environment of teamwork built on quality relationships, your top performers will be happier, more productive, and enjoy the workplace. People happy with their environment are more loyal, work harder, and are less likely to look elsewhere for a new opportunity

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.justotherarticles.org.ua/article/20384/justotherarticles-Social-Network-Analysis--Are-You-Important.html">Social Network Analysis - Are You Important?</a>

BB link (for phorums):
[url=http://www.justotherarticles.org.ua/article/20384/justotherarticles-Social-Network-Analysis--Are-You-Important.html]Social Network Analysis - Are You Important?[/url]

The Internet played a critical role in bringing the tobacco companies to justice. In the future, consumers will use the Internet in a similar way to go after, and bring down, other rogue industries, politicians and government agencies. Read why and how the ground rules have changed forever in this article.

The revolution in the advertising industry has necessitated a change in the traditional mode of advertising. Newspapers, radio, television, direct mailers, or even the Internet is no longer enough to meet the demands of the various advertising needs. In today's demanding times, the call is for a different kind of infusion that can pump up the advertising campaign. This infusion forms specialty advertising.

Help Desk Outsourcing is the responsible for checking and troubleshooting the problems occurring in computer and the similar products and applications being used in the company.

Tags

Links

Just Other Articles - Social Network Analysis - Are You Important?

Related Articles: